These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 6969759

  • 1. Mechanisms in T cell leukemogenesis. II. T cell responses of preleukemic BALB/c mice to Moloney leukemia virus antigens.
    Lee JC, Horak I, Ihle JN.
    J Immunol; 1981 Feb; 126(2):715-22. PubMed ID: 6969759
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. T cell recognition of Moloney sarcoma virus proteins during tumor regression. I. Lack of a requirement for macrophages and the role of blastogenic factors in T cell proliferation.
    Enjuanes L, Lee JC, Ihle JN.
    J Immunol; 1981 Apr; 126(4):1478-84. PubMed ID: 6970777
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Influence of genotype and the organ of origin on the subtype of T-cell in Moloney lymphomas induced by transfer of preleukemic cells from athymic and thymus-bearing mice.
    Asjö B, Skoog L, Palminger I, Wiener F, Isaak D, Cerny J, Fenyö EM.
    Cancer Res; 1985 Mar; 45(3):1040-5. PubMed ID: 3871660
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Down-regulation of natural killer cell activity in MoLV leukemogenesis: evidence for tumor-cell-mediated suppression.
    Ofir R, Weinstein Y, Rager-Zisman B.
    Nat Immun Cell Growth Regul; 1988 Mar; 7(2):77-86. PubMed ID: 2842667
    [Abstract] [Full Text] [Related]

  • 11. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV).
    Zanovello P, Collavo D, Ronchese F, De Rossi A, Biasi G, Chieco-Bianchi L.
    Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P, Biasi G, Horvath C, Cerottini JC, MacDonald HR.
    J Immunol; 1998 Feb 15; 160(4):1659-65. PubMed ID: 9469422
    [Abstract] [Full Text] [Related]

  • 15. Effects of murine leukemia viruses on the function of dendritic cells.
    Gabrilovich DI, Roberts MS, Harvey JJ, Botcherby M, Bedford PA, Knight SC.
    Eur J Immunol; 1993 Nov 15; 23(11):2932-8. PubMed ID: 8223870
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus.
    Genovesi EV, Collins JJ.
    J Cell Physiol; 1983 Nov 15; 117(2):215-29. PubMed ID: 6630299
    [Abstract] [Full Text] [Related]

  • 18. Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors.
    Gorczynski RM, Knight RA.
    Eur J Immunol; 1975 Feb 15; 5(2):148-55. PubMed ID: 1086221
    [Abstract] [Full Text] [Related]

  • 19. Incidence and phenotypic heterogeneity of Moloney virus-induced leukemias: a multigenic control.
    Debre P, Gisselbrecht S, Boyer B, Levy JP.
    Blood Cells; 1981 Feb 15; 7(2):301-11. PubMed ID: 6975141
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.